health pharma news today obesity drugs glp-1 Giants Bet on Next-Generation Treatments to Sustain Growth The GLP-1 Revolution: How Next-Generation
Description
They are typically accessed through in-person or telehealth prescriber visits and filled at retail pharmacies
Oral GLP-1s create a pathway to manage cost and scale access, but next-gen injectables will continue to reset the clinical ceiling (and member expectations)
Individual results will vary based on starting weight, age, metabolic health, adherence to post-operative guidelines, and other personal health factors
Endocrine Reviews, 44 , 1432
Isolation of the Peptide
For patients who cannot take stimulants unlike phentermine, Contrave is non-stimulant
